PT  - JOURNAL ARTICLE
AU  - IHME COVID-19 Forecasting Team
AU  - Simon I Hay
TI  - COVID-19 scenarios for the United States
AID  - 10.1101/2020.07.12.20151191
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.12.20151191
4099  - http://medrxiv.org/content/early/2020/07/14/2020.07.12.20151191.short
4100  - http://medrxiv.org/content/early/2020/07/14/2020.07.12.20151191.full
AB  - The United States (US) has not been spared in the ongoing pandemic of novel coronavirus disease1,2. COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to cause death and disease in all 50 states, as well as significant economic damage wrought by the non-pharmaceutical interventions (NPI) adopted in attempts to control transmission3. We use a deterministic, Susceptible, Exposed, Infectious, Recovered (SEIR) compartmental framework4,5 to model possible trajectories of SARS-CoV-2 infections and the impact of NPI6 at the state level. Model performance was tested against reported deaths from 01 February to 04 July 2020. Using this SEIR model and projections of critical driving covariates (pneumonia seasonality, mobility, testing rates, and mask use per capita), we assessed some possible futures of the COVID-19 pandemic from 05 July through 31 December 2020. We explored future scenarios that included feasible assumptions about NPIs including social distancing mandates (SDMs) and levels of mask use. The range of infection, death, and hospital demand outcomes revealed by these scenarios show that action taken during the summer of 2020 will have profound public health impacts through to the year end. Encouragingly, we find that an emphasis on universal mask use may be sufficient to ameliorate the worst effects of epidemic resurgences in many states. Masks may save as many as 102,795 (55,898–183,374) lives, when compared to a plausible reference scenario in December. In addition, widespread mask use may markedly reduce the need for more socially and economically deleterious SDMs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Bill & Melinda Gates Foundation, as well as funding from the state of Washington and the National Science Foundation (2031096). We also extend a note of particular thanks to John Stanton and Julie Nordstrom for their generous support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study uses only anonymised, aggregated, de-identified data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll estimates can be further explored through our customized online data visualization tools (https://covid19.healthdata.org/united-states-of-america). The findings of this study are supported by data available in public online repositories, data publicly available upon request of the data provider, and data not publicly available owing to restrictions by the data provider. Non-publicly available data were used under license for the current study but may be available from the authors upon reasonable request and with permission of the data provider. Detailed tables and figures of data sources and availability can be found in SI Figures 1-4, and SI Tables 1-11. All maps presented in this study are generated by the authors using RStudio (R Version 3.6.3) and no permissions are required to publish them. Administrative boundaries were retrieved from the Database of Global Administrative Areas (GADM). Land cover was retrieved from the online Data Pool, courtesy of the NASA EOSDIS Land Processes Distributed Active Archive Center (LP DAAC), USGS/Earth Resources Observation and Science (EROS) Center, Sioux Falls, South Dakota. Populations were retrieved from WorldPop (https://www.worldpop.org). https://covid19.healthdata.org/united-states-of-america